Effect of patient education and physical training on quality of life and physical exercise capacity in patients with paroxysmal or persistent atrial fibrillation:A randomized study by Joensen, Albert M et al.
 
  
 
Aalborg Universitet
Effect of patient education and physical training on quality of life and physical exercise
capacity in patients with paroxysmal or persistent atrial fibrillation
A randomized study
Joensen, Albert M; Dinesen, Pia T; Svendsen, Lotte T; Hoejbjerg, Tina K; Fjerbaek, Annette;
Andreasen, Jane; Sottrup, Maria B; Lundbye-Christensen, Soren; Vadmann, Henrik; Riahi,
Sam
Published in:
Journal of Rehabilitation Medicine
DOI (link to publication from Publisher):
10.2340/16501977-2551
Creative Commons License
CC BY-NC 4.0
Publication date:
2019
Document Version
Publisher's PDF, also known as Version of record
Link to publication from Aalborg University
Citation for published version (APA):
Joensen, A. M., Dinesen, P. T., Svendsen, L. T., Hoejbjerg, T. K., Fjerbaek, A., Andreasen, J., Sottrup, M. B.,
Lundbye-Christensen, S., Vadmann, H., & Riahi, S. (2019). Effect of patient education and physical training on
quality of life and physical exercise capacity in patients with paroxysmal or persistent atrial fibrillation: A
randomized study. Journal of Rehabilitation Medicine, 51(6), 442-450. https://doi.org/10.2340/16501977-2551
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
            ? Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
            ? You may not further distribute the material or use it for any profit-making activity or commercial gain
            ? You may freely distribute the URL identifying the publication in the public portal ?
JR
M
JR
M
Jo
ur
na
l o
f 
R
eh
ab
ili
ta
ti
on
 M
ed
ic
in
e
JR
M
Jo
ur
na
l o
f 
R
eh
ab
ili
ta
ti
on
 M
ed
ic
in
e
Journal Compilation © 2019 Foundation of Rehabilitation Information. ISSN 1650-1977
This is an open access article under the CC BY-NC license. www.medicaljournals.se/jrm
doi: 10.2340/16501977-2551
ORIGINAL REPORT
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PERSISTENT ATRIAL FIBRILLATION: A RANDOMIZED STUDY
Albert M. JOENSEN, MD, PhD1,2, Pia T. DINESEN, MD, PhD1,2, Lotte T. SVENDSEN, RN1, Tina K. HOEJBJERG, RN1, 
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LAY ABSTRACT
Atrial fibrillation is the most common cardiac arrhythmia 
and the number of atrial fibrillation patients is growing 
worldwide. In addition to an increase in risk of stroke 
and heart failure patients with atrial fibrillation also ex-
perience decrease in fitness and quality of life. In our 
study 58 atrial fibrillation patients draw lots to partici-
pate or not in a rehabilitation program with education 
and exercise training in addition to usual treatment. We 
measured fitness by a bicycle test at the beginning of 
the study and after 3 and 6 months, moreover partici-
pants filled out questionnaires on quality of life at the 
beginning of the study and after 3, 6 and 12 months. 
We found that our rehabilitation program may have a 
short term (but no long term) effect on quality of life 
and fitness in atrial fibrillation patients.
Objective: To examine the effect of a rehabi-
litation programme on quality of life and phy-
sical capacity in patients with atrial fibrillation. 
Methods: Patients with paroxysmal or persistent 
atrial fibrillation were randomized to either a 12-
week rehabilitation programme with education and 
physical training (intervention group) or standard 
care (control group). At baseline, after 3, 6 and 12 
months participants completed 5 different quality of 
life questionnaires (Quality of Life in patients with 
Atrial Fibrillation (AF-QoL-18), Atrial Fibrillation Ef-
fect on QualiTy of Life (AFEQT), Patient Health Ques-
tionnaire (PHQ-9), Generalised Anxiety Disorder 
Assessment (GAD-7) and EuroQol 5D (EQ-5D)), and 
physical exercise tests. Differences in mean] scores 
between groups were analysed by repeated measu-
res analysis of variance (ANOVA). 
Results: Fifty-eight patients (age range 43–78 years, 
31% female) were included. In the intervention gro-
up the AF-QoL-18 score increased from baseline (48.4 
(standard deviation (SD) 22.8)) to 6 months (68.0 
(SD 15.2)) compared with the control group (base-
line 51.6 (SD 22.3), 6 months 59.2 (SD 27.3)). After 
12 months, there was no difference. Similar patterns 
were found for the other questionnaires. Maximum 
exercise capacity improved in the intervention group 
from baseline (176 W (SD 48)) to 6 months (190 W 
(SD 55)). There was no change in the control group. 
Conclusion: Education and physical training may 
have a short-term (but no long-term) beneficial ef-
fect on quality of life and physical exercise capacity 
in patients with atrial fibrillation.
Key words: atrial fibrillation; rehabilitation; quality of life; 
physical exercise; education.
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Cardiac rehabilitation takes a cross-functional approach to the aftercare of patients, including individually de-
signed treatment plans, patient information and education 
plans, physical exercise, dietary guidance, psychosocial 
support, optimization of medical treatment, risk factor 
control, and individual maintenance of treatment goals. 
There is strong evidence that rehabilitation has a be-
neficial effect on quality of life (QoL) in patients with 
coronary heart disease (CHD) (1). However, patients with 
atrial fibrillation (AF) are seldom and not systematically 
offered rehabilitation.
Previous studies have demonstrated that patients 
with AF lack knowledge regarding the natural history 
of AF, consequences, treatment and how to manage a 
change in QoL caused by AF (2). 
In addition, the relationship between physical exer-
cise and AF has been disputed. Among 64,561 patients, 
Qureshi et al. found an inverse relationship between 
cardiorespiratory fitness and incident AF, especially 
in obese subjects who underwent exercise treadmill 
testing (3). In 825 obese patients with AF, Pathak et 
al. demonstrated a lower burden of AF in patients 
who lost weight and improved their cardiorespiratory 
fitness (4, 5). Pathak et al. also demonstrated a bene-
ficial effect of aggressive risk factor management on 
the long-term success of AF ablation (6). Randomized 
studies on patients with primarily permanent AF have 
demonstrated beneficial effects of physical exercise 
on physical capacity, AF symptoms and QoL (7–11).
The prevalence of AF is increasing (12), therefore, 
it is important to investigate whether a rehabilitation 
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443Patient education and physical training for patients with AF
programme can improve QoL and physical exercise 
capacity in patients with AF and, potentially, prevent 
readmissions.
Objective
The aim of this study was to investigate whether a 
rehabilitation programme with group education, phy-
sical exercise, optimization of medical treatment and 
monitoring of lifestyle changes can improve QoL and 
physical exercise capacity in patients with AF.
METHODS 
Design
Clinical randomized controlled trial. ClinicalTrials.gov (record 
N-20120002).
Patients
Patients with paroxysmal or persistent AF admitted to the De-
partment of Cardiology, Aalborg University Hospital between 
6 June 2012 and 4 April 2013 were consecutively invited to 
participate in the study. All patients received treatment according 
to the current guidelines. Patients who provided informed 
consent to participate were randomized to either specialized 
cardiac rehabilitation or standard follow-up. The rehabilitation 
programme consisted of groups of 10 patients. 
At the primary admission, all patients underwent echocardio-
graphy and blood samples were taken.
Inclusion criteria. Patients ≥ 18 years of age, hospitalized at the 
Department of Cardiology, Aalborg University Hospital, with 
a diagnosis of paroxysmal or persistent AF documented by an 
electrocardiogram (ECG) or > 30 s of AF recorded by long-term 
monitoring. All participants received oral and written informa-
tion prior to providing written informed consent.
Exclusion criteria. atients who qualified for cardiac rehabilita-
tion due to other cardiac conditions (congestive heart failure or 
CHD) were excluded. If AF was caused by a reversible condition 
patients were also excluded.
Heart failure (New York Heart Association (NYHA) class 
III–IV or Left Ventricular Ejection Fraction (LVEF) < 40%) or 
valvular heart disease and patients admitted for radiofrequency 
ablation were also excluded. Patients considered too ill, phy-
sically or mentally, to participate in rehabilitation by the treating 
physicians were excluded. 
Randomization
Randomization was electronically, randomizing the participants 
into 2 groups of 20 participants at a time.
Rehabilitation
The rehabilitation programme included education, physical 
exercise, optimization of the medical treatment and discussion 
of implications on daily life.
The group sessions with a doctor, a nurse, a dietician or a psy-
chologist was scheduled once a week for 1 h for the first 8 weeks. 
The education included information on pathophysiology, risk 
factors, treatment, diet and coping mechanisms for living with AF.
The exercise programme was conducted as 1-h sessions twice 
a week for 12 weeks and supervised by a cardiac rehabilitation 
physiotherapist. Each training session consisted of at least 30 
min of aerobics ≥ 70% of maximum exercise capacity estimated 
from a maximum cycle ergometer test with ECG monitoring 
and graded on the Borg scale (score 14–16) and interval training 
with elements of strengthening exercises (13).
Patients were encouraged to be moderately physically active 
≥ 30 min each day and, if they missed a group training session, 
to perform 30 min of high-intensity activities.
Medication
The medical treatment was optimized according to the current 
guidelines.
Quality of life
At inclusion and after 3, 6 and 12 months, all participants 
completed the following disease-specific QoL questionnaires: 
Health-related Quality of Life in patients with Atrial Fibrilla-
tion (AF-QoL-18) and Atrial Fibrillation Effect on QualiTy of 
Life (AFEQT) and the generic QoL questionnaires: Generalised 
Anxiety Disorder Assessment (GAD-7), Patient Health Ques-
tionnaire (PHQ-9) and EuroQol 5D (EQ-5D).
AF-QoL-18 includes 18 questions on 3 domains: psychologi-
cal, physical and sexual activity. The answer score range from 
zero (worst) to 100 (best). AFEQT includes 20 questions on 
treatment, symptoms and daily activity during the last 4 weeks. 
The score range from 20 (best) to 140 (worst).
GAD-9 assesses anxiety and results range from zero (worst) 
to 21 (best). PHQ-9 focuses on depression symptoms during the 
latest 2 weeks ranging from zero (best) to 27 (worst). EQ-5D 
consists of 5 questions on mobility, self-care, usual activities, 
pain/discomfort, anxiety/depression and a visual analogue scale 
(EQVAS) assessing self-estimated health status.
Physical exercise tests
At inclusion and after 3 and 6 months, all participants were 
tested by an ergometer cycle test, a 6-min walk (6MW) test 
and a 5-repetition-sit-to-stand (5RSS) test.
The ergometer cycle test was performed in accordance with 
the standard for exercise testing of the American Heart Associa-
tion (14). The maximal physical capacity test was used as an 
indirect measure of the maximum exercise capacity. Participants 
started at 50 Watt (W), with a 25-W load increase for each 2 
min until the participants could no longer maintain a speed of 
60 rotations/min due to fatigue/dyspnoea. 
The 6MW test is a simple, safe and inexpensive test to estima-
te submaximum exercise capacity. The test results correlate well 
with functional capacity and can be used prognostically (15).
The 5RSS test is also a simple, safe and inexpensive test 
evaluating the strength of the lower extremities by the patient 
standing up from a sitting position as quickly as possible 5 
times in a row (16). 
All tests were performed by one of 2 trained physiotherapists, 
who were blinded to whether the participant participated in 
rehabilitation.
Statistical analysis
Quality of life. From the study by Arribas et al. in 2010 (17), 
mean and standard deviation (SD) of AF-QoL-18 in a population 
of Spanish patients with AF were stated to be: mean 38.9 and 
J Rehabil Med 51, 2019
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(SD 21.5). With a level of significance of 0.05, a power of 0.8 
and a difference between groups of 17 (corresponding to, for 
example, means 39 and 22), the necessary number of patients 
in each randomization arm is n = 26. No power calculation was 
made in relation to the other questionnaires. 
Maximum exercise capacity. Hegbom et al., in 2006 (7), com-
pared changes in maximum exercise capacity between 2 groups 
of patients with AF, of which only one group received active 
exercise therapy. From this paper, mean and SD of changes in 
measure of maximum exercise capacity (CW max) are stated as 
0.3 and 0.26 (W × min), respectively. With a level of significance 
of 0.05, a power of 0.8 and a difference between groups of 0.3 
(corresponding to, for example, means before/after of 1.3/1.6 
for the active group and 1.3/1.3 for the passive group), the ne-
cessary number of patients in each randomization arm is n = 16.
The differences in time course in mean outcome values bet-
ween the 2 randomization groups at baseline and at 3, 6 and 12 
months were analysed by repeated measures ANOVA, taking 
into account the within-patient correlation. All hypotheses were 
specified a priori, thus, no corrections for multiple testing were 
made (18). Assumptions of normality and variance homogen-
eity were assessed by residual plots. Sensitivity analyses were 
performed using robust variance estimation to manage potential 
variance heterogeneity, using log-transformed data to accom-
modate right skewness and using bootstrap when assumptions 
in general were not met. Stata statistical software (version 
13; StataCorp LP, College Station, TX, USA) was used for 
randomization and analyses. Two-tailed p-values <0.05 were 
considered statistically significant. 
Ethical issues
All patients received oral and written information, emphasizing 
that participating in the study was voluntary and withdrawing 
their informed consent at any time would not affect the present 
or future treatment. The project was approved by the local ethics 
committee (approval number N-20120002) and conducted in 
conformity with the Declaration of Helsinki.
Data were collected according to the principles of good 
clinical practice and the project was reported to the Danish Data 
Protection Agency (2008-58-0028).
RESULTS
A total of 823 patients were screened. The majority 
of patients did not meet the inclusion criteria (Fig. 1). 
The low inclusion rate (7%) was explained mainly by 
exclusion of patients who were eligible for other reha-
bilitation programmes or experienced comorbidities. 
Consequently, 90 patients eligible for inclusion were 
invited to participate in the study, of whom 58 (64%) 
accepted the invitation. Barriers to participation were 
mostly time-consumption or not being able to partici-
pate due to the patients’ work. 
Two patients from the rehabilitation group and 4 
from the control group did not return the questionnaires 
and were lost to follow-up. Over 80% of the interven-
tion group participated in ≥ 75% of the rehabilitation 
programme.
Baseline characteristics of participants are listed in 
Table I.
Questionnaires
For all QoL questionnaires, the trend was an increase 
in QoL from the baseline to 6 months questionnaire, 
which was higher in the intervention group than in 
the control group, although not all differences were 
statistically significant. 
Using the AF-QoL-18 questionnaire, we found 
that the intervention group had a significantly higher 
increase in score during the first 6 months, but only 
a minor not statistically significant difference at 12 
months (Table II and Fig. 2a). When separating the AF-
QoL-18 into the 3 domains (physical, psychological 
and sexual activity), we found the same trend in all 3 
sub-analyses, with the most pronounced effect in the 
physical domain (data not shown).
Results from the AFEQT questionnaire were similar 
(Table II and Fig. 2b).
Fig. 1. Fig. 1. Flowchart of participants. RFA: radio frequency ablation, 
AF: atrial fibrillation.
823 patients screened 
for the study 
235 patients deemed to 
be too ill
43 patients dropped off 
for temporary causes
268 patients had 
coronary heart disease 
or congestive heart 
faliure
24 patients were 
excluded for other 
reasons
52 patients had 
permanent AF
111 patients received 
RFA
58 patients included
90 patients invited to 
participate
28 patients in control 
group
30 patients in 
intervention group
www.medicaljournals.se/jrm
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445Patient education and physical training for patients with AF
The PHQ9 and GAD questionnaires showed that 
patients in both groups achieved a higher QoL after 6 
months, but the increase was statistically significantly 
higher in the intervention group. From 6 to 12 months 
a lower QoL was found in both groups without statis-
tical significance at the end of the study (Table II and 
Figs 2c and 2d).
A similar trend was found using the EQVAS, 
with an initial not statistically significant in-
crease in QoL for the intervention group that de-
creased at the end of the study (Table II and Fig. 2e). 
Physical training
As shown in Fig. 3 and Table III, the participants in 
the intervention group had a lower maximum exercise 
capacity and oxygen (O2) uptake and an inferior per-
formance in the 5RSS test at baseline than the control 
group despite the electronic randomization. The control 
group did not improve their exercise capacity and O2 
uptake during the study, whereas in the intervention 
group, the maximum exercise capacity increased signi-
ficantly from baseline to 3 months and remained steady 
Table I. Baseline characteristics of participants. All values are given as numbers unless otherwise stated in the table
Control group (n = 24) Intervention group (n = 28) p-value for difference
Age, years, mean (SD) [range] 60.2 (8.9) [42.7–73.4] 62.2 (10.0) [32.6–77.6) 0.447
Female, n (%) 7 (29) 11 (39) 0.562
AF type, n (%)   0.177
  Paroxysmal 9 (38) 16 (57)  
  Persistent 15 (63) 12 (43)  
CHADS2VA2Sc score, n (%) 0.673
  0 9 (38) 6 (21)
  1 8 (33) 11 (39)
  2 5 (21) 7 (25)
  3 2 (8) 4 (14)
Symptoms, n (%)    
  Fatigue 11 (46) 12 (43) 1.000
  Dyspnoea 9 (38) 11 (39) 1.000
  Palpitations 10 (42) 14 (50) 0.588
  Dizziness 6 (25) 11 (393) 0.376
  Syncope 1 (4) 3 (10) 0.615
  Chest pain 10 (42) 7 (25) 2.450
  Asymptomatic 3 (13) 5 (18) 0.711
Smoker, n (%) 1 (4) 1 (4) 1.000
BMI, kg/m2, mean (SD) [range] 27.8 (3.9) [22.1–40.4] 27.9 (5.1) [21.1–43.4] 0.963
Oxygen uptake, l/min/kg, mean (SD) [range] 31.7 (8.3) [15.4–50.1] 29.0 (7.3) [16.5–42.0] 0.230
Medical treatment, n (%)    
  Warfarin 11 (46) 11 (39) 0.779
  Dabigatran 3 (13) 2 (7) 0.652
  ASA 2 (8) 2 (7) 1.000
  Beta blocker 16 (67) 18 (64) 1.000
  Amiodarone 2 (8) 3 (11) 1.000
  Flecainide 4 (17) 3 (11) 0.690
BMI: body mass index; AF: atrial fibrillation; SD: standard deviation; ASA: acetylsalicylic acid.
Table II. Scores from quality of life (QoL) questionnaires at baseline and after 3, 6 and 12 months. The first column with p-values 
stems from the unpaired comparison between treatment groups at baseline. Subsequent p-values stem from unpaired comparisons of 
changes from baseline
Questionnaire
Baseline 3 months 6 months 12 months
Mean (SD) p-value Mean (SD) p-value Mean (SD) p-value Mean (SD) p-value
AF-QoL-18 Control 52.2 (22.1) 57.3 (24.7) 59.2 (27.28) 58.0 (28.0)
Intervention 48.4 (22.8) 0.555 63.2 (18.9) 0.014* 68.0 (15.21) 0.031* 59.1 (23.2) 0.359
AFEQT Control 66.3 (26.5) 78.2 (20.9) 82.3 (18.7) 83.4 (19.3)
Intervention 67.5 (26.3) 0.841 86.4 (19.5) 0.194 88.6 (15.1) 0.822 86.7 (20.5) 0.812
GAD-7 Control 3.6 (3.9) 2.4 (3.5) 3.0 (3.1) 3.3 (3.5)
Intervention 5.3 (4.9) 0.092 2.7 (3.6) 0.071 1.6 (2.1) 0.003* 3.2 (4.2) 0.074
PHQ-9 Control 4.3 (4.3) 4.2 (3.7) 3.9 (3.5) 4.8 (5.0)
Intervention 5.8 (7.3) 0.251 3.3 (3.6) 0.082 1.8 (2.5) 0.023* 3.4 (3.8) 0.028*
EQVAS Control 76.2 (13.2) 73.4 (14.4) 77.0 (12.1) 77.8 (11.0)
Intervention 71.0 (15.9) 0.184 75.4 (15.9) 0.062 80.0 (11.0) 0.099 76.2 (15.0) 0.362
*p-values from analysis of variance (ANOVA) test of difference between groups from baseline to time-point  
QoL: quality of life; SD: standard deviation; AFEQT: Atrial Fibrillation Effect on QualiTy of Life; GAD-7: Generalised Anxiety Disorder Assessment; PHQ-9: Patient 
Health Questionnaire; EQ-5D: EuroQol 5D.
J Rehabil Med 51, 2019
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until 6 months. The maximum O2 uptake increased 
from 29.0 ml O2/kg (SD 7.3) at baseline to 31.1 (SD 
7.4) after 6 months. 
In the 5RSS test, the rehabilitation group improved 
during the first 3 months and remained approximately 
the same for the next 3 months. The control group 
remained at the same level during the first 3 months 
but improved from 3 to 6 months. Thus, the difference 
between the 2 groups was the same at 6 months as at 
baseline (Fig. 3 and Table III).
In the 6MW test, the baseline mean distance was 
similar between groups. A small improvement was 
observed in both groups from baseline to 6 months, but 
no statistically significant difference between groups.
Nine patients had AF during one or more of the 
physical tests. Stratification for AF or sinus rhythm did 
Fig. 2a–e. Quality of life (QoL) scores (using 5 different QoL 
questionnaires) for patients with atrial fibrillation (AF) randomized 
to participate in a 12-week multifaceted rehabilitation programme vs 
usual care at 3, 6 and 12 months after inclusion in the study. Shown 
with 95% confidence intervals (95% CI). (a) Quality of Life in patients 
with Atrial Fibrillation (AF-QoL) (b) Atrial Fibrillation Effect on QualiTy 
of Life (AFEQT:) (c) Generalised Anxiety Disorder Assessment (GAD-
7) (d) Patient Health Questionnaire (PHQ-9); (e) visual analogue 
scale (EQVAS).
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not change the results of the physical tests significantly, 
but wider confidence intervals were observed.
Plots of residuals showed no violations of model as-
sumptions. Sensitivity analyses confirmed our findings. 
Hence, the conclusions did not depend on a normal 
distribution of data or variance/covariance structure of 
data. Stratification by physical capacity at baseline, age, 
sex and type of AF did not differ from the main results.
No patients experienced adverse events during 
training.
During the study period, 38 patients had at least one 
readmission for cardiac reasons, mostly AF (rehabilita-
tion group: 20 and control group: 18), 25 had at least 
one direct current cardioversion (rehabilitation group: 
13 and control group: 12) and 11 had a radiofrequency 
ablation (rehabilitation group: 7 and control group: 
Fig. 3a–d. Results from physical tests for patients with atrial fibrillation (AF) randomized to participate in a 12-week rehabilitation programme 
including physical exercise and education vs usual care at baseline and 3 and 6 months after inclusion in the study. Shown with 95% confidence 
intervals (95% CI). (a) Maximum exercise capacity; (b) maximum O2 uptake; (c) Five-repetition-sit-to-stand test; (d) 6-min walk test.
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Table III. Results of physical score tests at baseline and after 3 and 6 months. The first column with p-values stems from the unpaired 
comparison between treatment groups at baseline. The subsequent p-values stem from unpaired comparisons of changes from baseline
Physical score test
Baseline 3 months 6 months
Mean (SD) p-value Mean (SD) p-value Mean (SD) p-value
Maximum exercise capacity, Watt Control 204 (68) 206 (68) 193 (65)
Intervention 176 (48) 0.073 189 (56) 0.012* 190 (55) 0.026*
O2 uptake, ml/kg/min Control 31.7 (8.3) 31.8 (8.7) 30.8 (8.8)
Intervention 29.0 (7.3) 0.200 30.1 (7.7) 0.125 31.1 (7.4) 0.079
5-repetition-sit-to-stand test, s Control 7.8 (2.4) 7.8 (2.6) 6.9 (2.1)
Intervention 9.2 (3.2) 0.058 7.8 (2.5) 0.011* 7.8 (3.1) 0.490
6-min walk test, m Control 596 104.3) 630 (100) 637 (104)
Intervention 613 (96) 0.951 608 (104) 0.138 644 84) 0.734
*p-values from analysis of variance (ANOVA) test of difference between groups from baseline to time-point. 
SD: standard deviation.
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4). There was no statistically significant difference 
between groups.
DISCUSSION
This study found that a full rehabilitation programme 
including group education and physical training for 
patients with paroxysmal or persistent AF was bene-
ficial, with statistically significant improvement of 
QoL measured with both disease-specific (AF-QoL-18, 
AFEQT) and non-disease-specific (GAD-7, PHQ-9, 
EQ-5D) questionnaires during the first 6 months, after 
which the effect attenuated. 
Five different questionnaires were used to assess 
different aspects of QoL. In all questionnaires, there 
was an increase in QoL for all participants from the 
start to the end of the study, which was consistent with 
results from other studies (19, 20). The intervention 
group experienced a higher increase in QoL during the 
first 6 months (although not statistically significant in 
all questionnaires) and a subsequent attenuation of the 
intervention effect compared with the control group. 
An earlier study regarding the AFEQT questionnaire 
suggested that a mean change of approximately 12 
points was correlated with a small improvement and 
< 5.3 points was an unimportant improvement (21). Our 
study showed a difference of 7.6 points after 3 months, 
potentially suggesting a small clinical importance.
In addition, a positive effect was found on maximum 
O2 uptake, whereas no convincing improvement was 
found in the other physical tests. 
At baseline, there was a statistically significant 
difference between the intervention and the control 
group in the performance of the physical tests despite 
randomization. However, this did not have any statis-
tically significant effect on the results, as stratification 
by O2 uptake at baseline did not show a different effect 
of training in patients with a low O2 uptake compared 
with those with a high uptake. 
Physical exercise has been shown to reduce the risk 
and magnitude of, for example, hypertension, diabetes 
mellitus and obesity, and has been shown to be benefi-
cial for patients with CHD and congestive heart failure 
(22, 23). Thus, physical exercise may potentially lead 
to a reduction in the risk of developing AF. However, 
long duration of vigorous training may increase the risk 
of developing AF (8), although it seems that moderate 
physical exercise have a protective effect on patients 
with permanent AF (8, 24). Regarding physical exer-
cise and non-permanent AF, Malmo et al. (25) found 
that aerobic interval training reduced the time in AF 
and improved QoL estimated from the Short Form-
36 (SF-36) questionnaire. Furthermore, training also 
significantly improved AF symptoms, VO2 peak, left 
atrial and ventricular function. 
Risom et al. (26) conducted a 12-week randomized 
trial on rehabilitation for patients with paroxysmal or 
persistent AF after catheter ablation. The authors found 
an improved physical capacity assessed by VO2 peak, 
which is in line with our results. The authors did not 
find a statistically significant improvement in the 6MW 
test in the training group compared with the control 
group, which was comparable with our results. They 
did not find an improvement of the mental health based 
on a non-disease specific questionnaire. As radiofre-
quency ablation was an exclusion criterion in our study 
the results cannot be directly compared.
Skielboe et al. included 76 patients with paroxysmal 
or persistent AF who were randomized to high- or 
low-intensity exercise for 12 weeks. Both groups im-
proved their peak VO2 significantly (11). QoL was not 
measured. Recent studies have compared AF patients 
and non-AF patients who joined a cardiac rehabilita-
tion programme for other cardiovascular diseases or 
cardiovascular risk factors. Younis et al. found that 
patients with AF initially had lower physical capacity 
than non-AF participants, but improvement in physical 
capacity diminished the risk of total mortality and car-
diovascular hospitalization for both groups (27). In a 
case control study Reed et al. found that rehabilitation 
improved QoL in both groups, but to a greater extent 
in patients without AF (28).
Although patients with paroxysmal AF may be in si-
nus rhythm most of the time, they may be less likely to 
be physically active because of anxiety about initiating 
AF (29). Even when patients were in sinus rhythm, this 
study showed that QoL and physical capacity could be 
improved. We also found an improvement of the 6MW 
test in the control group, perhaps because participating 
in the study encouraged patients to be more physically 
active even though they were in the control group. The 
bicycle tests favoured the intervention group, proba-
bly because bicycle training was a central part of the 
physical exercise programme. 
Establishing whether physical exercise in patients 
with AF would be beneficial to reduce the risk of co-
morbidities and the burden of AF will require larger 
studies with longer follow-up.
The rehabilitation programme seemed to have the 
highest impact on reducing anxiety and depression 
and increasing physical and psychological well-being 
(estimated by questionnaires with focus on these 
domains: AF-QoL-18, GAD-7 and PHQ-9) and al-
leviating patients’ symptoms (as assessed by AFEQT). 
www.medicaljournals.se/jrm
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Strengths
The strengths of this study include a complete re-
habilitation programme, the use of disease-specific 
individualized training programmes and exercise tests 
performed by physiotherapists who were blinded to 
the 2 groups. 
The study included patients with paroxysmal or 
persistent AF, whereas other studies have primarily 
included patients with permanent AF. Thus, in gene-
ral, participants in our study seemed to have higher 
baseline scores compared with an unselected popula-
tion of AF (17). Dudrik et al. have previously shown 
that progression from paroxysmal to persistent AF is 
associated with a decrease in health-related quality of 
life (30). We therefore performed stratified analyses on 
type of AF, but we did not find any differences in the 
effect of rehabilitation between the 2 groups.
This study examined the effect of a complete rehabi-
litation programme for patients with AF. Previous stu-
dies have shown beneficial effects of education about 
anticoagulation treatment on treatment compliance and 
found that physical training was beneficial regarding 
physical capacity and QoL (7, 9, 24, 28). In addition, 
non-randomized studies indicated a beneficial effect 
of physical exercise, weight loss, and aggressive risk 
factor management (5–7).
Limitations
The primary limitation was the number of participants, 
although it was comparable with other studies in 
patients with AF (7–11). The physical training of the 
control group was not monitored. Due to logistics we 
could not include all relevant patients. Patients could 
not be included if they were admitted for a short period 
when no nurse or physicians leading the study were 
on duty, However, this is non-systematic selection and 
could therefore not influence the study results. Also, a 
precise registration of the AF burden would have been 
optimal, e.g. implanting a loop-recorder. However, the 
economy of the study was restricted. No information 
was collected regarding the degree of the patients’ 
physical activity during the follow-up period, which 
could affect the QoL scores.
Thus, this study has limitations. No long-term po-
sitive effect of patient education and physical training 
on QoL of the studied patients was found. Therefore, 
the cost-effectiveness of this rehabilitation programme 
for this patient group is questionable.
Conclusion
This study indicated that a multifaceted rehabilitation 
programme including education and physical training 
in patients with paroxysmal or persistent AF may have 
a beneficial short-term (but no long-term) effect on 
QoL and physical exercise capacity estimated with 
disease-specific and generic QoL questionnaires.
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